IL6 and rheumatoid arthritis: In 2020, Kim et al. assessed VEGF, placenta growth factor (PlGF), sFlt-1, and IL-6 levels in the synovial fluid and/or serum of patients with RA, and analyzed their possible correlations with US assessment of synovitis, as well as with therapeutic responses to csDMARDs versus bDMARDs.